Feed
Search
Sign in
Company
Private
South San Francisco, CA
Terremoto Biosciences, Inc
Stories only
SEC EDGAR
ClinicalTrials.gov
1
Story in coverage
0
Programs
1
1 recruiting
Registered trial
8-K
Oct 27
Latest SEC filing
Form D
Apr 22
$41M sold
Timeline
1
Pipeline
0
Trials
1
All
1
Filings and people
1
October 2026
Faeth Therapeutics adds Zymeworks R&D chief Adam Schayowitz to board
Oct 27
People
Faeth Therapeutics
Sign in